Bayesian Capital Management LP bought a new position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,813 shares of the company's stock, valued at approximately $819,000.
A number of other institutional investors also recently added to or reduced their stakes in MOH. Versant Capital Management Inc boosted its stake in shares of Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after purchasing an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. acquired a new stake in Molina Healthcare in the fourth quarter valued at $52,000. Hurley Capital LLC bought a new position in shares of Molina Healthcare during the 4th quarter worth approximately $55,000. EverSource Wealth Advisors LLC grew its stake in Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after buying an additional 88 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd increased its position in Molina Healthcare by 895.0% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock worth $58,000 after buying an additional 179 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Stock Down 0.6 %
NYSE:MOH traded down $2.02 during trading hours on Friday, hitting $323.84. 602,871 shares of the company traded hands, compared to its average volume of 681,091. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a market cap of $17.55 billion, a PE ratio of 15.85, a PEG ratio of 1.06 and a beta of 0.63. The firm's 50-day simple moving average is $324.73 and its 200-day simple moving average is $308.25. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the company earned $5.73 earnings per share. Equities analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Insider Buying and Selling
In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This represents a 25.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now directly owns 11,244 shares in the company, valued at approximately $3,603,702. This trade represents a 5.62 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is owned by company insiders.
Analyst Ratings Changes
Several equities analysts have commented on MOH shares. Robert W. Baird reissued a "neutral" rating and issued a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. StockNews.com upgraded shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, April 11th. Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Truist Financial lifted their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Nine investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $365.38.
Check Out Our Latest Analysis on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.